Genetic variation in the human hepatic cytochrome P-450 system
- 1 January 1987
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 31 (6) , 633-641
- https://doi.org/10.1007/bf00541288
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenololXenobiotica, 1986
- The molecular mechanisms of two common polymorphisms of drug oxidation-evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidationXenobiotica, 1986
- IntroductionXenobiotica, 1986
- Sparteine Oxidation Polymorphism in DenmarkActa Pharmacologica et Toxicologica, 1985
- A cytochrome P‐450 gene family mapped to human chromosome 19Annals of Human Genetics, 1985
- Localization of the human aryl hydrocarbon hydroxylase gene to the 2q31→2pter region of chromosome 2Annals of Human Genetics, 1985
- A human cytochrome P-450 characterized by inhibition studies as the sparteine–debrisoquine monooxygenaseCanadian Journal of Physiology and Pharmacology, 1984
- Oral Hypoglycaemic Agents An UpdateDrugs, 1984
- Variations in Aryl Hydrocarbon Hydroxylase Activities in Mitogen-Activated Human and Nonhuman Primate LymphocytesToxicologic Pathology, 1984
- The Problem of Chemically Reactive MetabolitesDrug Metabolism Reviews, 1982